Copyright
©The Author(s) 2025.
World J Clin Cases. Dec 26, 2025; 13(36): 113655
Published online Dec 26, 2025. doi: 10.12998/wjcc.v13.i36.113655
Published online Dec 26, 2025. doi: 10.12998/wjcc.v13.i36.113655
Table 1 Timeline of illness and clinical findings
| Day | Clinical events and findings | Key actions |
| Day 0 | Onset of mild rhinorrhea and cough after exposure to family members with viral laryngitis | Watchful monitoring |
| Day 3 | Cough worsened, mild change in voice. No fever | Single daily ibuprofen dose started |
| Day 5 | Fever up to 39 °C, decreased appetite, tachypnea, mild wheezing, SpO2 = 84% (room air) | Azithromycin and ibuprofen initiated. Nitazoxanide (60 mg twice daily) added based on uridine diphosphate-glucuronosyltransferase 1A1 enzyme maturation data (Strassburg et al[23], 2002) |
| Day 6 | Fever subsided; wheezing more evident; no signs of respiratory distress or consolidation | Ibuprofen discontinued; paracetamol as needed |
| Day 7-10 | Gradual improvement of cough, tachypnea and general condition; SpO2 = 92% | Continued hydration and supportive care including alpha amylase, levocetrizine and benproperine |
| Day 14 | Full clinical recovery; SpO2 = 96% (room air) | All treatments completed |
| Day 28 | Follow-up showed sustained clinical recovery. No deterioration or relapse |
- Citation: Kelleni MT. First use of nitazoxanide in Kelleni’s protocol for managing severe bronchiolitis in a 9-month-old infant: A case report and review of literature. World J Clin Cases 2025; 13(36): 113655
- URL: https://www.wjgnet.com/2307-8960/full/v13/i36/113655.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v13.i36.113655
